Table 3 Standardised incidence ratios (SIRs) and their 95% CIs for oesophageal cancer by histology among unoperated patients with gastric ulcer, by follow‐up duration, sex, presence of complications and calendar year of index hospitalisation*.
Adenocarcinoma | Squamous cell carcinoma | |||
---|---|---|---|---|
Number of cases | SIR (95% CI) | Number of cases | SIR (95% CI) | |
Overall | 18 | 1.1 (0.6–1.7) | 70 | 1.8 (1.4–2.3) |
Follow‐up duration, years | ||||
2–10 | 12 | 1.1 (0.6–2.0) | 48 | 1.8 (1.3–2.4) |
11+ | 6 | 1.0 (0.4–2.2) | 22 | 1.9 (1.2–2.9) |
Sex | ||||
Men | 15 | 1.1 (0.6–1.9) | 53 | 2.0 (1.5–2.6) |
Women | 3 | 0.9 (0.2–2.7) | 17 | 1.5 (0.8–2.3) |
Complication† | ||||
Yes | 11 | 1.1 (0.6–2.0) | 39 | 1.7 (1.2–2.3) |
No | 7 | 1.1 (0.4–2.2) | 31 | 2.1 (1.4–2.9) |
Calendar year of index hospitalisation | ||||
1965–79 | 4 | 1.0 (0.3–2.4) | 26 | 1.9 (1.2–2.8) |
1980–2003 | 14 | 1.1 (0.6–1.9) | 44 | 1.8 (1.3–2.4) |
Age at entry | ||||
<50 | 2 | 1.2 (0.1–4.2) | 10 | 3.2 (1.5–5.8) |
50–69 | 10 | 1.2 (0.6–2.3) | 43 | 2.2 (1.6–3.0) |
70– | 6 | 0.9 (0.3–1.9) | 17 | 1.1 (0.6–1.7) |
P for trend | 0.49 | <0.01 | ||
Calendar year of follow‐up | ||||
1965–94 | 5 | 0.8 (0.3–1.9) | 38 | 1.6 (1.1–2.2) |
1995–2003 | 13 | 1.3 (0.7–2.1) | 32 | 2.2 (1.5–3.1) |
*First year of follow‐up was excluded
†Including bleeding and perforation.